| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |